Supernus Pharmaceuticals SUPN

$ 35.71 -1.14%

Quarterly report 2024-Q3
added 11-04-2024

Supernus Pharmaceuticals Balance Sheet 2011-2024 | SUPN

Annual Balance Sheet Supernus Pharmaceuticals

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-50.3 M	-156 M	76.9 M	329 M	301 M	-100 M	-38.5 M	1.08 M	28.5 M	50.6 M	-17.4 M	-19.1 M
Long Term Debt	36 M	41.3 M	362 M	345 M	329 M	-	4.16 M	7.19 M	26.9 M	34.4 M	11.1 M	22.7 M
Long Term Debt Current	6.79 M	6.48 M	3.76 M	2.82 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	404 M	363 M	34 M	37.1 M	13.8 M	38.7 M	51.1 M	13.4 M	25.5 M
Total Current Liabilities	688 M	315 M	245 M	161 M	161 M	123 M	80.7 M	56.9 M	27.5 M	26.4 M	23 M	-
Total Liabilities	816 M	873 M	759 M	565 M	525 M	157 M	118 M	69.9 M	66.2 M	77.5 M	36.4 M	44.3 M
Deferred Revenue	-	-	-	-	-	287 K	209 K	176 K	143 K	8.09 M	508 K	232 K
Retained Earnings	481 M	380 M	326 M	200 M	86.5 M	-26.8 M	-84.3 M	-145 M	-159 M	-179 M	-86.3 M	-40 M
Total Assets	1.7 B	1.69 B	1.5 B	1.16 B	978 M	424 M	310 M	189 M	138 M	111 M	94 M	53.7 M
Cash and Cash Equivalents	93.1 M	203 M	289 M	181 M	192 M	100 M	66.4 M	33.5 M	36.4 M	33 M	40.3 M	48.5 M
Book Value	886 M	816 M	745 M	595 M	453 M	267 M	192 M	119 M	71.4 M	33.5 M	57.6 M	9.44 M
Total Shareholders Equity	886 M	816 M	745 M	595 M	453 M	267 M	192 M	88 M	40.7 M	33.5 M	57.6 M	9.44 M

All numbers in USD currency

Quarterly Balance Sheet Supernus Pharmaceuticals

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	28.9 M	30.3 M	33 M	33.2 M	33.8 M	34.2 M	36.5 M	36 M	-	-	39.9 M	379 M	-	-	18.5 M	20.2 M	20.2 M	20.2 M	20.2 M	-	-	-	30.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23.2 M	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	336 M	358 M	375 M	356 M	373 M	373 M	880 M	816 M	840 M	854 M	811 M	873 M	745 M	787 M	753 M	759 M	759 M	759 M	759 M	565 M	565 M	565 M	565 M	525 M	525 M	525 M	525 M	157 M	157 M	157 M	157 M	118 M	118 M	118 M	118 M	101 M	101 M	101 M	101 M	96.1 M	96.1 M	66.2 M	66.2 M	77.5 M	77.5 M	77.5 M	77.5 M	36.4 M	36.4 M	36.4 M	36.4 M	44.3 M	44.3 M	44.3 M	44.3 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	287 K	287 K	287 K	287 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	508 K	576 K	365 K	232 K	232 K	232 K	232 K	232 K
Retained Earnings	541 M	503 M	483 M	483 M	481 M	497 M	498 M	481 M	456 M	454 M	446 M	380 M	377 M	356 M	332 M	326 M	326 M	326 M	326 M	200 M	200 M	200 M	200 M	86.5 M	86.5 M	86.5 M	86.5 M	-26.8 M	-26.8 M	-26.8 M	-26.8 M	-84.3 M	-84.3 M	-84.3 M	-84.3 M	-176 M	-176 M	-176 M	-176 M	-189 M	-189 M	-159 M	-159 M	-179 M	-179 M	-179 M	-179 M	-86.3 M	-86.3 M	-86.3 M	-86.3 M	-40 M	-40 M	-40 M	-40 M
Total Assets	1.34 B	1.32 B	1.3 B	1.28 B	1.29 B	1.29 B	1.79 B	1.7 B	1.69 B	1.69 B	1.64 B	1.69 B	1.56 B	1.57 B	1.51 B	1.5 B	1.5 B	1.5 B	1.5 B	1.16 B	1.16 B	1.16 B	1.16 B	978 M	978 M	978 M	978 M	424 M	424 M	424 M	424 M	310 M	310 M	310 M	310 M	189 M	189 M	189 M	189 M	137 M	137 M	138 M	138 M	111 M	111 M	111 M	111 M	94 M	94 M	94 M	94 M	53.7 M	53.7 M	53.7 M	53.7 M
Cash and Cash Equivalents	31.7 M	52.1 M	63.4 M	75.1 M	95 M	24.7 M	58.4 M	93.1 M	111 M	173 M	116 M	203 M	215 M	224 M	256 M	289 M	289 M	289 M	289 M	181 M	181 M	181 M	181 M	192 M	192 M	192 M	192 M	100 M	100 M	100 M	100 M	66.4 M	66.4 M	66.4 M	66.4 M	33.5 M	33.5 M	33.5 M	33.5 M	36.4 M	36.4 M	36.4 M	36.4 M	33 M	33 M	33 M	33 M	40.3 M	40.3 M	40.3 M	40.3 M	48.5 M	48.5 M	48.5 M	48.5 M
Book Value	1.01 B	957 M	929 M	922 M	912 M	920 M	912 M	886 M	853 M	841 M	828 M	816 M	810 M	786 M	754 M	745 M	745 M	745 M	745 M	595 M	595 M	595 M	595 M	453 M	453 M	453 M	453 M	267 M	267 M	267 M	267 M	192 M	192 M	192 M	192 M	88 M	88 M	88 M	88 M	40.7 M	40.7 M	71.4 M	71.4 M	33.5 M	33.5 M	33.5 M	33.5 M	57.6 M	57.6 M	57.6 M	57.6 M	9.44 M	9.44 M	9.44 M	9.44 M
Total Shareholders Equity	1.01 B	957 M	929 M	922 M	912 M	920 M	912 M	886 M	853 M	841 M	828 M	816 M	810 M	786 M	754 M	745 M	745 M	745 M	745 M	595 M	595 M	595 M	595 M	453 M	453 M	453 M	453 M	267 M	267 M	267 M	267 M	192 M	192 M	192 M	192 M	88 M	88 M	88 M	88 M	40.7 M	40.7 M	71.4 M	71.4 M	33.5 M	33.5 M	33.5 M	33.5 M	57.6 M	57.6 M	57.6 M	57.6 M	9.44 M	9.44 M	9.44 M	9.44 M

All numbers in USD currency